Effect of Embryo transfers day on infertility treatment

Determine predictive factors of embryo transfer on day 2 versus day 3 on intracytoplasmic sperm injection-embryo transfer cycles clinical outcomes.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014121420306N1

Enrollment

300

Registered

2015-01-02

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the genitourinary system. Noninflammatory disorders of female genital tract

Interventions

Intervention 1: Control group: The embryo transfer carried out on day3. Intervention 2: Intervention: Embryo transfer carried out on day2.

Treatment - Other

Control group: The embryo transfer carried out on day3.

Intervention: Embryo transfer carried out on day2.

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women aged 20-40 years old undergoing fresh intracytoplasmic sperm injection-embryo transfer cycles; have normal endometrial thickness (7-12 milimeters) on embryo transfers day; don't have any visible endometrial pathology; do not have more than three failed previous intracytoplasmic sperm injection-embryo transfer cycles. Exclusion criteria: abnormally shaped uterus in hysterosalpingography or hysteroscopy; have more than 3 previous failure of intracytoplasmic sperm injection-embryo transfer cycles .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate. Timepoint: Five weeks after start of intervention. Method of measurement: Transvaginal ultrasonography.;Predicting factors. Timepoint: End of the treatment. Method of measurement: Statistical analysis.	—

Secondary

Measure	Time frame
Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Labratory kit.;Ongoing pregnancy rate. Timepoint: 10weeks after embryo transfer. Method of measurement: History, physical exam, ultrasonography.;Miscariage rate. Timepoint: Until 24 weeks after start of intervention. Method of measurement: History, Physical exam, Ultrasonography.;Fertilization rate. Timepoint: After embryo development. Method of measurement: Labratory investigation.;Implantation rate. Timepoint: Two weeks after embryo transfer. Method of measurement: History, Physical exam, Ultrasonography.	—

Measure

Time frame

Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Labratory kit.;Ongoing pregnancy rate. Timepoint: 10weeks after embryo transfer. Method of measurement: History, physical exam, ultrasonography.;Miscariage rate. Timepoint: Until 24 weeks after start of intervention. Method of measurement: History, Physical exam, Ultrasonography.;Fertilization rate. Timepoint: After embryo development. Method of measurement: Labratory investigation.;Implantation rate. Timepoint: Two weeks after embryo transfer. Method of measurement: History, Physical exam, Ultrasonography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Zademodarres

Infertility & Reproductive Health Research Center Shahid Beheshti University of Medical Science

shahrzad.modarres2014@gmail.com+98 21 5530 1452

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026